Therapeutic interventions have seen significant enhancements, particularly in the management of respiratory and cardiovascular disorders. The development of surfactant therapy has dramatically improved outcomes for premature infants with respiratory distress syndrome. Additionally, the use of ECMO has proven life-saving for neonates with severe cardiac and respiratory failure. These advancements have reduced mortality rates and improved long-term health outcomes.
